Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced
that the Company has dismissed Ernst & Young (“E&Y”) as its public
accounting firm, effective July 5, 2014, due to E&Y’s determination that
it was not independent solely as a result of an inappropriate personal
relationship between an E&Y partner and Ventas’s former Chief Accounting
Officer and Controller. Ventas also announced that, following such
dismissal, its Audit Committee has engaged KPMG LLP (“KPMG”) as the
Company's independent public accounting firm.
E&Y has advised the Company that, solely due to the inappropriate
personal relationship, it determined that it was not independent of the
Company during the periods in question. As a result of such
determination, E&Y stated that it was obligated under applicable law and
professional standards to withdraw (and it has withdrawn) its audit
reports on the Company’s financial statements for the years ended
December 31, 2012 and 2013, and its review of the Company’s results for
the quarter ended March 31, 2014. E&Y’s decision to withdraw such audit
reports and review was made exclusively due to the personal relationship
in question, and not for any reason related to Ventas’s financial
statements, its accounting practices, the integrity of Ventas’s controls
or for any other reason.
Ventas believes that the Company’s financial statements present fairly,
in all material respects, the financial condition, results of operations
and cash flows of the Company as of the end of and for the referenced
periods, and may continue to be relied upon. The Company also believes
that its internal control over financial reporting was effective during
those periods. Ventas noted that the senior E&Y partner on the Ventas
account, who signed the 2012 and 2013 audit reports, was not the
individual involved in the inappropriate personal relationship.
As the Company’s new independent public accounting firm, KPMG has been
engaged to complete a re-audit and re-review of the relevant periods.
The Company will devote all necessary resources to facilitate KPMG’s
completion of its work on an expedited basis. There can be no assurance
that KPMG will reach the same conclusions as E&Y regarding the
application of accounting standards, management estimates or other
factors affecting the Company’s financial statements.
The Company also announced today the separation of Robert J. Brehl from
his position as Ventas’s Chief Accounting Officer and Controller in
relation to these matters. Mr. Brehl’s separation from the Company was
not due to any disagreement with the Company regarding its financial
reporting or accounting operations, policies or practices.
“Ventas stands for integrity, reliability and transparency with
investors, lenders, employees and other stakeholders,” stated Ventas
Chairman and Chief Executive Officer Debra A. Cafaro. “When we learned
of this isolated situation, we investigated the facts immediately,
notified E&Y promptly and took swift and decisive action.
“Our team of experienced professionals remains focused on executing our
strategic plan, including completion of our two previously announced
acquisitions of American Realty Capital Healthcare Trust, Inc. and the
29 independent living seniors housing communities located in Canada from
Holiday Retirement, in accordance with their terms.”
Richard A. Schweinhart, Executive Vice President and Chief Financial
Officer of the Company, has assumed Mr. Brehl’s responsibilities and
will serve as the Company’s Acting Chief Accounting Officer. To the
extent requested by the Company and the Ventas Board of Directors, Mr.
Schweinhart has also agreed to modify and/or defer his previously
announced retirement plans to ensure completion of the re-audit work and
a smooth transition to his successor.
VENTAS ISSUES SECOND QUARTER 2014 NORMALIZED FFO GUIDANCE
Ventas said that it currently expects its second quarter 2014 normalized
FFO per diluted share to be at least $1.09. The Company’s guidance
represents at least eight percent per share growth in normalized FFO
compared to the comparable 2013 period. A reconciliation of the
Company’s guidance to the Company’s projected GAAP earnings is attached
to this press release.
The Company expects to release financial results for the second quarter
2014 within the customary second quarter reporting cycle.
Mr. Schweinhart said, “Our financial position remains strong and we look
forward to reporting our second quarter results. I have confidence in
the professionalism and commitment of my team, and we are fully engaged
to ensure that KPMG will be able to complete its work.”
The Company’s normalized FFO guidance (and related GAAP earnings
projections) for all periods assumes, with certain immaterial
exceptions, that all of the Company’s tenants and borrowers continue to
meet all of their obligations to the Company. In addition, the Company’s
normalized FFO guidance excludes, other than as specifically stated, (a)
net gains on the sales of real property assets, including gain on
re-measurement of equity method investments, (b) merger-related costs
and expenses, including amortization of intangibles, transition and
integration expenses, and deal costs and expenses, (c) the impact of any
expenses related to asset impairment and valuation allowances, the
write-off of unamortized deferred financing fees, or additional costs,
expenses, discounts, make-whole payments, penalties or premiums incurred
as a result of early retirement or payment of debt, (d) the non-cash
effect of income tax benefits or expenses and derivative transactions
that have non-cash mark-to-market impacts on the Company’s income
statement, (e) the impact of future unannounced acquisitions or
divestitures (including pursuant to tenant options to purchase) and
capital transactions, (f) the financial impact of contingent
consideration, severance-related costs, charitable donations made to the
Ventas Charitable Foundation, gains and losses for non-operational
foreign currency hedge agreements and changes in the fair value of
financial instruments and (g) expenses related to the re-audit and
re-review of the Company’s historical financial results and related
matters.
The Company’s guidance is based on a number of other assumptions that
are subject to change and many of which are outside the control of the
Company. If actual results vary from these assumptions, the Company’s
expectations may change. There can be no assurance that the Company will
achieve these results. The Company may from time to time update its
publicly announced guidance, but it is not obligated to do so.
Ventas, Inc., an S&P 500 company, is a leading real estate investment
trust. Its diverse portfolio of nearly 1,500 assets in 47 states
(including the District of Columbia), two Canadian provinces and the
United Kingdom consists of seniors housing communities, medical office
buildings, skilled nursing facilities, hospitals and other properties.
Through its Lillibridge subsidiary, Ventas provides management, leasing,
marketing, facility development and advisory services to highly rated
hospitals and health systems throughout the United States. More
information about Ventas and Lillibridge can be found at www.ventasreit.com
and www.lillibridge.com.
This press release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements regarding the results of the re-audit and re-review of the
Company’s financial statements, the Company’s or its tenants’,
operators’, borrowers’ or managers’ expected future financial condition,
results of operations, cash flows, funds from operations, dividends and
dividend plans, financing opportunities and plans, capital markets
transactions, business strategy, budgets, projected costs, operating
metrics, capital expenditures, competitive positions, acquisitions,
investment opportunities, dispositions, merger integration, growth
opportunities, expected lease income, continued qualification as a real
estate investment trust (“REIT”), plans and objectives of management for
future operations and statements that include words such as
“anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,”
“may,” “could,” “should,” “will” and other similar expressions are
forward-looking statements. These forward-looking statements are
inherently uncertain, and actual results may differ from the Company’s
expectations. The Company does not undertake a duty to update these
forward-looking statements, which speak only as of the date on which
they are made.
The Company’s actual future results and trends may differ materially
from expectations depending on a variety of factors discussed in the
Company’s filings with the SEC. These factors include without
limitation: (a) the ability and willingness of the Company’s tenants,
operators, borrowers, managers and other third parties to satisfy their
obligations under their respective contractual arrangements with the
Company, including, in some cases, their obligations to indemnify,
defend and hold harmless the Company from and against various claims,
litigation and liabilities; (b) the ability of the Company’s tenants,
operators, borrowers and managers to maintain the financial strength and
liquidity necessary to satisfy their respective obligations and
liabilities to third parties, including without limitation obligations
under their existing credit facilities and other indebtedness; (c) the
Company’s success in implementing its business strategy and the
Company’s ability to identify, underwrite, finance, consummate and
integrate diversifying acquisitions and investments, including
investments in different asset types and outside the United States; (d)
macroeconomic conditions such as a disruption of or lack of access to
the capital markets, changes in the debt rating on U.S. government
securities, default or delay in payment by the United States of its
obligations, and changes in the federal or state budgets resulting in
the reduction or nonpayment of Medicare or Medicaid reimbursement rates;
(e) the nature and extent of future competition, including new
construction in the markets in which the Company’s seniors housing
communities and medical office buildings (“MOBs”) are located; (f) the
extent of future or pending healthcare reform and regulation, including
cost containment measures and changes in reimbursement policies,
procedures and rates; (g) increases in the Company’s borrowing costs as
a result of changes in interest rates and other factors; (h) the ability
of the Company’s operators and managers, as applicable, to comply with
laws, rules and regulations in the operation of the Company’s
properties, to deliver high-quality services, to attract and retain
qualified personnel and to attract residents and patients; (i) changes
in general economic conditions or economic conditions in the markets in
which the Company may, from time to time, compete, and the effect of
those changes on the Company’s revenues, earnings and funding sources;
(j) the Company’s ability to pay down, refinance, restructure or extend
its indebtedness as it becomes due; (k) the Company’s ability and
willingness to maintain its qualification as a REIT in light of
economic, market, legal, tax and other considerations; (l) final
determination of the Company’s taxable net income for the year
ended December 31, 2013 and for the year ending December 31, 2014; (m)
the ability and willingness of the Company’s tenants to renew their
leases with the Company upon expiration of the leases, the Company’s
ability to reposition its properties on the same or better terms in the
event of nonrenewal or in the event the Company exercises its right to
replace an existing tenant or manager, and obligations, including
indemnification obligations, the Company may incur in connection with
the replacement of an existing tenant or manager; (n) risks associated
with the Company’s senior living operating portfolio, such as factors
that can cause volatility in the Company’s operating income and earnings
generated by those properties, including without limitation national and
regional economic conditions, costs of food, materials, energy, labor
and services, employee benefit costs, insurance costs and professional
and general liability claims, and the timely delivery of accurate
property-level financial results for those properties; (o) changes in
exchange rates for any foreign currency in which the Company may, from
time to time, conduct business; (p) year-over-year changes in the
Consumer Price Index or the UK Retail Price Index and the effect of
those changes on the rent escalators contained in the Company’s leases
and the Company’s earnings; (q) the Company’s ability and the ability of
its tenants, operators, borrowers and managers to obtain and maintain
adequate property, liability and other insurance from reputable,
financially stable providers; (r) the impact of increased operating
costs and uninsured professional liability claims on the Company’s
liquidity, financial condition and results of operations or that of the
Company’s tenants, operators, borrowers and managers, and the ability of
the Company and the Company’s tenants, operators, borrowers and managers
to accurately estimate the magnitude of those claims; (s) risks
associated with the Company’s MOB portfolio and operations, including
the Company’s ability to successfully design, develop and manage MOBs,
to accurately estimate its costs in fixed fee-for-service projects and
to retain key personnel; (t) the ability of the hospitals on or near
whose campuses the Company’s MOBs are located and their affiliated
health systems to remain competitive and financially viable and to
attract physicians and physician groups; (u) the Company’s ability to
build, maintain and expand its relationships with existing and
prospective hospital and health system clients; (v) risks associated
with the Company’s investments in joint ventures and unconsolidated
entities, including its lack of sole decision-making authority and its
reliance on its joint venture partners’ financial condition; (w) the
impact of market or issuer events on the liquidity or value of the
Company’s investments in marketable securities; (x) merger and
acquisition activity in the seniors housing and healthcare industries
resulting in a change of control of, or a competitor’s investment in,
one or more of the Company’s tenants, operators, borrowers or managers
or significant changes in the senior management of the Company’s
tenants, operators, borrowers or managers; (y) the impact of litigation
or any financial, accounting, legal or regulatory issues that may affect
the Company or its tenants, operators, borrowers or managers; and (z)
changes in accounting principles, or their application or
interpretation, and the Company’s ability to make estimates and the
assumptions underlying the estimates, which could have an effect on
earnings. Many of these factors are beyond the control of the Company
and its management.
|
NON-GAAP FINANCIAL MEASURES RECONCILIATION
|
|
Normalized FFO Per Diluted Share Reconciliation for the Three
Months Ended June 30, 20141
|
|
|
|
|
|
|
|
|
|
|
|
Guidance
|
|
|
|
|
|
For the Three Months
|
|
|
|
|
|
Ended
|
|
|
|
|
|
June 30, 2014
|
|
|
|
|
|
|
Net income attributable to common stockholders
|
|
|
|
|
$
|
0.44
|
Adjustments:
|
|
|
|
|
|
Depreciation and amortization on real estate assets, depreciation
on
|
|
|
|
|
|
|
real estate assets related to noncontrolling interest and
unconsolidated
|
|
|
|
|
|
|
entities, and gain/loss on dispositions of real estate assets, net
|
|
|
|
|
|
0.60
|
FFO
|
|
|
|
|
|
1.04
|
Adjustments:
|
|
|
|
|
|
Income tax benefit/expense, net gain/loss on the extinguishment of
|
|
|
|
|
|
|
debt, merger-related expenses and deal costs, change in fair value
|
|
|
|
|
|
|
of financial instruments and amortization of other intangibles
|
|
|
|
|
|
0.05
|
Normalized FFO
|
|
≥
|
|
|
$
|
1.09
|
|
|
|
|
|
|
1 All amounts reported herein are preliminary estimates
and are subject to change.
|
|
Click
here to subscribe to Mobile Alerts for Ventas, Inc.
Copyright Business Wire 2014